Can reduced co-pays boost outcomes, lower costs in diabetic patients?
Maybe not immediately, but investigators at the University of Michigan think the long-term answer may well be "yes." And what's more, there may even be a positive impact on overall medical costs. Definitive answers should be forthcoming soon as a just-lanched pilot study will be examining both of these issues over the next two years.